重组细胞因子

• ACE2 acts as a tumor suppressor in breast cancer by inhibiting progression via the TGF-β1/Smad pathway and potentiating immune checkpoint blockade. BBA - Molecular Basis of Disease, Volume 1872, Issue 5, June 2026, 168224. (IF 4.2)(Human TGF-β1)
• Microfluidic Nanocomposite Lubricating Microgels Localized Deliver Celastrol for Remodeling the Immune Microenvironment to Enhance Osteoarthritis Treatment. Research 2026;9:Article 1124. (IF 10.9)(Human IL-1β)
• Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials. Acta Pharmaceutica Sinica B.2025,,ISSN 2211-3835. (IF 14.6)(Mouse IL-4, Mouse IL-13)
• Engineered Self-Activatable Polymeric Nanozymes Precisely Eradicate Tumor-Associated Intramacrophage Bacteria to Potentiate Immunotherapy Based on Cluster of Differentiation 47 Blockade. ACS Nano. 2026 Feb 19. (IF 16.1)(Mouse IL-13)
• Fluorinated amphipathic cationic peptides for intracellular protein delivery and cancer immunotherapy. Nano Today,Volume 68,2026,102979,ISSN 1748-0132. (IF 10.9)(Mouse IL-4, Mouse GM-CSF)
• MITA/STING-driven CD38 induction in Siglec-Flow macrophages promotes regulatory T cell survival and non-small cell lung cancer progression. Dev Cell. 2026 Jan 12:S1534-5807(25)00768-3.(IF 8.7)(Mouse M-CSF)